367 related articles for article (PubMed ID: 30343529)
1. High-throughput screening in colorectal cancer tissue-originated spheroids.
Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
[TBL] [Abstract][Full Text] [Related]
2. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
3. In vivo and ex vivo cetuximab sensitivity assay using three-dimensional primary culture system to stratify KRAS mutant colorectal cancer.
Tashiro T; Okuyama H; Endo H; Kawada K; Ashida Y; Ohue M; Sakai Y; Inoue M
PLoS One; 2017; 12(3):e0174151. PubMed ID: 28301591
[TBL] [Abstract][Full Text] [Related]
4. Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation.
Endo H; Okami J; Okuyama H; Kumagai T; Uchida J; Kondo J; Takehara T; Nishizawa Y; Imamura F; Higashiyama M; Inoue M
J Thorac Oncol; 2013 Feb; 8(2):131-9. PubMed ID: 23328545
[TBL] [Abstract][Full Text] [Related]
5. A Novel Multiparametric Drug-Scoring Method for High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Cribbes S; Kessel S; McMenemy S; Qiu J; Chan LL
SLAS Discov; 2017 Jun; 22(5):547-557. PubMed ID: 28346096
[TBL] [Abstract][Full Text] [Related]
6. Radiation sensitivity assay with a panel of patient-derived spheroids of small cell carcinoma of the cervix.
Nakajima A; Endo H; Okuyama H; Kiyohara Y; Kimura T; Kamiura S; Hiraoka M; Inoue M
Int J Cancer; 2015 Jun; 136(12):2949-60. PubMed ID: 25408479
[TBL] [Abstract][Full Text] [Related]
7. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
8. RNAi High-Throughput Screening of Single- and Multi-Cell-Type Tumor Spheroids: A Comprehensive Analysis in Two and Three Dimensions.
Fu J; Fernandez D; Ferrer M; Titus SA; Buehler E; Lal-Nag MA
SLAS Discov; 2017 Jun; 22(5):525-536. PubMed ID: 28277887
[TBL] [Abstract][Full Text] [Related]
9. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
10. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
[TBL] [Abstract][Full Text] [Related]
11. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
12. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
Pasch CA; Favreau PF; Yueh AE; Babiarz CP; Gillette AA; Sharick JT; Karim MR; Nickel KP; DeZeeuw AK; Sprackling CM; Emmerich PB; DeStefanis RA; Pitera RT; Payne SN; Korkos DP; Clipson L; Walsh CM; Miller D; Carchman EH; Burkard ME; Lemmon KK; Matkowskyj KA; Newton MA; Ong IM; Bassetti MF; Kimple RJ; Skala MC; Deming DA
Clin Cancer Res; 2019 Sep; 25(17):5376-5387. PubMed ID: 31175091
[TBL] [Abstract][Full Text] [Related]
14. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
[TBL] [Abstract][Full Text] [Related]
15. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.
Jabs J; Zickgraf FM; Park J; Wagner S; Jiang X; Jechow K; Kleinheinz K; Toprak UH; Schneider MA; Meister M; Spaich S; Sütterlin M; Schlesner M; Trumpp A; Sprick M; Eils R; Conrad C
Mol Syst Biol; 2017 Nov; 13(11):955. PubMed ID: 29180611
[TBL] [Abstract][Full Text] [Related]
16. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
[TBL] [Abstract][Full Text] [Related]
17. iTRAQ Quantitative Proteomic Profiling and MALDI-MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device.
LaBonia GJ; Ludwig KR; Mousseau CB; Hummon AB
Anal Chem; 2018 Jan; 90(2):1423-1430. PubMed ID: 29227110
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
[TBL] [Abstract][Full Text] [Related]
19. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
[TBL] [Abstract][Full Text] [Related]
20. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
